Journal Browser
Journal Insights

Frequency: Half-yearly                    

Time to first decision: 2.4 Weeks

Submission to publication: 4 Weeks        

Acceptance rate: 26%

ISSN:  2972-3418

Open Access Review

Advances in the use of cell-membrane encapsulated nanoparticles to target tumor drugs

by Mengdie Feng a orcid  and  Yonghua Zheng b,* orcid
a
Baylor college of medicine, Houston, USA
b
Department of Pulmonary Medicine, Shanghai Jinshan Tinglin Hospital, Shanghai, China
*
Author to whom correspondence should be addressed.
BAB  2023, 10; 2(2), 10; https://doi.org/10.58567/bab02020001
Received: 5 September 2023 / Accepted: 8 October 2023 / Published: 9 October 2023

Abstract

Cancer treatment faces multiple challenges, including tumor heterogeneity, drug resistance, microenvironment influence, treatment side effects, and treatment cost. The heterogeneity of the tumor makes the effect of the same treatment vary in different patients, so the development of personalized treatment strategies is crucial. In addition, resistance of tumor cells to therapeutic drugs is a major challenge, and new strategies to overcome resistance are needed. As a cutting-edge field of science and technology, nanotechnology has brought great potential and opportunities for tumor treatment. Nanoparticle drug delivery systems improve drug efficacy and reduce side effects through precise targeted delivery and controlled release. Cell-membrane coated nanoparticles show great promise in tumor therapy. Nanoparticles coated with cell membranes have good biocompatibility, can reduce the obstacles of immune rejection and cell uptake, improve the accumulation and retention of drugs in tumor tissues, and have good drug delivery ability, drug stability and control release ability. This review discusses advances in the use of cell-membrane coated nanoparticles to target tumor drugs.


Copyright: © 2023 by Feng and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (Creative Commons Attribution 4.0 International License). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Show Figures

Share and Cite

ACS Style
Feng, M.; Zheng, Y. Advances in the use of cell-membrane encapsulated nanoparticles to target tumor drugs. Biomaterials and Biosensors, 2023, 2, 10. https://doi.org/10.58567/bab02020001
AMA Style
Feng M, Zheng Y. Advances in the use of cell-membrane encapsulated nanoparticles to target tumor drugs. Biomaterials and Biosensors; 2023, 2(2):10. https://doi.org/10.58567/bab02020001
Chicago/Turabian Style
Feng, Mengdie; Zheng, Yonghua 2023. "Advances in the use of cell-membrane encapsulated nanoparticles to target tumor drugs" Biomaterials and Biosensors 2, no.2:10. https://doi.org/10.58567/bab02020001
APA style
Feng, M., & Zheng, Y. (2023). Advances in the use of cell-membrane encapsulated nanoparticles to target tumor drugs. Biomaterials and Biosensors, 2(2), 10. https://doi.org/10.58567/bab02020001

Article Metrics

Article Access Statistics

References

  1. Liang W, Dong Y, Shao R, et al. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes[J]. J Drug Target, 2022, 30:463-475. https://doi.org/10.1080/1061186X.2021.2023160
  2. Choi MJ, Choi KC, Lee DH, et al. EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms[J]. Nanotechnol Sci Appl, 2022, 15:17-31. https://doi.org/10.2147/NSA.S352038
  3. Baghbanbashi M, Kakkar A. Polymersomes: Soft Nanoparticles from Miktoarm Stars for Applications in Drug Delivery[J]. Mol Pharm, 2022, 19:1687-1703. https://doi.org/10.1021/acs.molpharmaceut.1c00928
  4. Xiang G, Huo J, Liu Z. Understanding and application of metal-support interactions in catalysts for CO-PROX[J]. Phys Chem Chem Phys, 2022, 24:18454-18468. https://doi.org/10.1039/D2CP02035A
  5. Guo J, Huang L. Formulation of two lipid-based membrane-core nanoparticles for FOLFOX combination therapy[J]. Nat Protoc, 2022, 17:1818-1831. https://doi.org/10.1038/s41596-022-00698-3
  6. Kim HE, Kwon J, Lee H. Catalytic approaches towards highly durable proton exchange membrane fuel cells with minimized Pt use[J]. Chem Sci, 2022, 13:6782-6795. https://doi.org/10.1039/D2SC00541G
  7. Milogrodzka I, Nguyen Pham DT, Sama GR, et al. Effect of Cholesterol on Biomimetic Membrane Curvature and Coronavirus Fusion Peptide Encapsulation[J]. ACS Nano, 2023, 17:8598-8612. https://doi.org/10.1021/acsnano.3c01095
  8. Bao L, Dou G, Tian R, et al. Engineered neutrophil apoptotic bodies ameliorate myocardial infarction by promoting macrophage efferocytosis and inflammation resolution[J]. Bioact Mater, 2022, 9:183-197. https://doi.org/10.1016/j.bioactmat.2021.08.008
  9. Taghavi S, Tabasi H, Zahiri M, et al. Surface engineering of hollow gold nanoparticle with mesenchymal stem cell membrane and MUC-1 aptamer for targeted theranostic application against metastatic breast cancer[J]. Eur J Pharm Biopharm, 2023, 187:76-86. https://doi.org/10.1016/j.ejpb.2023.04.014
  10. Li Z, Cai H, Li Z, et al. A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody[J]. Bioact Mater, 2023, 21:299-312. https://doi.org/10.1016/j.bioactmat.2022.08.028
  11. Han S, Bi S, Guo T, et al. Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer[J]. J Control Release, 2022, 348:250-263. https://doi.org/10.1016/j.jconrel.2022.05.057
  12. Caggiano NJ, Wilson BK, Priestley RD, et al. Development of an In Vitro Release Assay for Low-Density Cannabidiol Nanoparticles Prepared by Flash NanoPrecipitation[J]. Mol Pharm, 2022, 19:1515-1525. https://doi.org/10.1021/acs.molpharmaceut.2c00041
  13. Li Y, Ruan S, Guo J, et al. B16F10 Cell Membrane-Based Nanovesicles for Melanoma Therapy Are Superior to Hyaluronic Acid-Modified Nanocarriers[J]. Mol Pharm, 2022, 19:2840-2853. https://doi.org/10.1021/acs.molpharmaceut.2c00212
  14. Ma Y, Gao W, Zhang Y, et al. Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis[J]. ACS Appl Mater Interfaces, 2022, 14:6358-6369. https://doi.org/10.1021/acsami.1c21700
  15. Rodriguez R, Palma MS, Bhandari D, et al. Electrodeposition of Ag/ZIF-8-Modified Membrane for Water Remediation[J]. Langmuir, 2023, 39:2291-2300. https://doi.org/10.1021/acs.langmuir.2c02947
  16. Liška V, Kubát P, Křtěnová P, et al. Magnetically Separable Photoactive Nanofiber Membranes for Photocatalytic and Antibacterial Applications[J]. ACS Omega, 2022, 7:47986-47995. https://doi.org/10.1021/acsomega.2c05935
  17. Ying K, Zhu Y, Wan J, et al. Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis[J]. Bioact Mater, 2023, 20:449-462. https://doi.org/10.1016/j.bioactmat.2022.06.013
  18. Czajka A, Byard SJ, Armes SP. Silica nanoparticle-loaded thermoresponsive block copolymer vesicles: a new post-polymerization encapsulation strategy and thermally triggered release[J]. Chem Sci, 2022, 13:9569-9579. https://doi.org/10.1039/D2SC02103J
  19. Xu C, Ban Q, Wang W, et al. Novel nano-encapsulated probiotic agents: Encapsulate materials, delivery, and encapsulation systems[J]. J Control Release, 2022, 349:184-205. https://doi.org/10.1016/j.jconrel.2022.06.061
  20. Harris JC, Sterin EH, Day ES. Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia[J]. ACS Biomater Sci Eng, 2022, 8:4439-4448. https://doi.org/10.1021/acsbiomaterials.2c00832
  21. Yang K, Han W, Jiang X, et al. Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration[J]. Nat Nanotechnol, 2022, 17:1322-1331. https://doi.org/10.1038/s41565-022-01225-x
  22. Zhang S, Li R, Zheng Y, et al. Erythrocyte Membrane-Enveloped Salvianolic Acid B Nanoparticles Attenuate Cerebral Ischemia-Reperfusion Injury[J]. Int J Nanomedicine, 2022, 17:3561-3577. https://doi.org/10.2147/IJN.S392089
  23. Cao H, Gao Y, Jia H, et al. Macrophage-Membrane-Camouflaged Nonviral Gene Vectors for the Treatment of Multidrug-Resistant Bacterial Sepsis[J]. Nano Lett, 2022, 22:7882-7891. https://doi.org/10.1021/acs.nanolett.2c02560
  24. Tomnikova A, Orgonikova A, Krizek T. Liposomes: preparation and characterization with a special focus on the application of capillary electrophoresis[J]. Monatsh Chem, 2022, 153:687-695. https://doi.org/10.1007/s00706-022-02966-0
  25. Yang C, Wu Y, Wang L, et al. Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2[J]. J Control Release, 2022, 345:537-548. https://doi.org/10.1016/j.jconrel.2022.03.038
  26. Martín-Pardillos A, Martín-Duque P. Nanoparticle (NP) Loading by Direct Incubation with Extracellular Vesicles-Secretor Cells: NP Encapsulation and Exosome Characterization[J]. Methods Mol Biol, 2023, 2668:121-132. https://doi.org/10.1007/978-1-0716-3203-1_10
  27. Guo Y, Li Y, Zhou S, et al. Metal-Organic Framework-Based Composites for Protein Delivery and Therapeutics[J]. ACS Biomater Sci Eng, 2022, 8:4028-4038. https://doi.org/10.1021/acsbiomaterials.0c01600